ONCOMED PHARMACEUTICALS INC filings

SEC filings by ONCOMED PHARMACEUTICALS INC (ownership)
TypeFiledFilerSubjectShares OwnedPercent Owned
SC 13D/A2019-04-26BIOTECHNOLOGY VALUE FUND L POncoMed Pharmaceuticals Inc-0.0%EDGAR
SC 13D2019-03-15BIOTECHNOLOGY VALUE FUND L POncoMed Pharmaceuticals Inc1,894,6574.9%EDGAR
SC 13G/A2019-02-14BIOTECHNOLOGY VALUE FUND L POncoMed Pharmaceuticals Inc1,850,3754.8%EDGAR
SC 13G/A2019-02-14PERCEPTIVE ADVISORS LLCOncoMed Pharmaceuticals Inc1,719,1114.5%EDGAR
SC 13G2019-02-14HARBOURVEST PARTNERS LLCOncoMed Pharmaceuticals Inc1,901,1064.9%EDGAR
SC 13G/A2019-02-13Phase4 Partners LtdOncoMed Pharmaceuticals Inc00.0%EDGAR
SC 13G/A2019-02-12DELPHI VENTURES VIII LPOncoMed Pharmaceuticals Inc1,991,6025.2%EDGAR
SC 13G/A2019-02-08PRIMECAP MANAGEMENT CO/CA/OncoMed Pharmaceuticals Inc5,506,30014.2%EDGAR
SC 13G2018-12-21HARBOURVEST PARTNERS LLCOncoMed Pharmaceuticals Inc1,941,0985.0%EDGAR
SC 13D2018-12-17Mereo Biopharma Group plcOncoMed Pharmaceuticals Inc4,130,90710.7%EDGAR
SC 13G/A2018-02-27PRIMECAP MANAGEMENT CO/CA/OncoMed Pharmaceuticals Inc5,565,60014.7%EDGAR
SC 13G/A2018-02-14BIOTECHNOLOGY VALUE FUND L POncoMed Pharmaceuticals Inc2,049,5925.4%EDGAR
SC 13G/A2018-02-14MORGENTHALER PARTNERS VII LPOncoMed Pharmaceuticals Inc-0.0%EDGAR
SC 13G/A2018-02-14PERCEPTIVE ADVISORS LLCOncoMed Pharmaceuticals Inc2,620,8976.9%EDGAR
SC 13G/A2018-02-13DELPHI VENTURES VIII LPOncoMed Pharmaceuticals Inc1,991,6025.3%EDGAR
SC 13G/A2018-01-31US VENTURE PARTNERS VIII L POncoMed Pharmaceuticals Inc00.0%EDGAR
SC 13G2017-12-06PERCEPTIVE ADVISORS LLCOncoMed Pharmaceuticals Inc2,470,8976.5%EDGAR
SC 13G2017-06-06PRIMECAP MANAGEMENT CO/CA/OncoMed Pharmaceuticals Inc5,503,60014.6%EDGAR
SC 13G/A2017-05-31BIOTECHNOLOGY VALUE FUND L POncoMed Pharmaceuticals Inc1,843,4844.9%EDGAR
SC 13G2017-04-27BIOTECHNOLOGY VALUE FUND L POncoMed Pharmaceuticals Inc1,372,9233.6%EDGAR